International Vaccine Institute (Ivi) 2024 Vaccine Biopharmaceutical International Standard Guideline Course Development And Education Impact Analysis Company Selection

국제백신연구소 South Korea has Released a tender for International Vaccine Institute (Ivi) 2024 Vaccine Biopharmaceutical International Standard Guideline Course Development And Education Impact Analysis Company Selection in Pharmaceuticals. The tender was released on Aug 08, 2024.

Country - South Korea

Summary - International Vaccine Institute (Ivi) 2024 Vaccine Biopharmaceutical International Standard Guideline Course Development And Education Impact Analysis Company Selection

Deadline - Aug 08, 2025

MT reference number - 90461687

Product classification - Business services: law, marketing, consulting, recruitment, printing and security

Organization Details:

  Address - South Korea

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90461687

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: International Vaccine Institute (Ivi) 2024 Vaccine Biopharmaceutical International Standard Guideline Course Development And Education Impact Analysis Company Selectionnotice_title: International Vaccine Institute (Ivi) 2024 Vaccine Biop harmaceutical International Standard Guideline Course Development And Education Impact Analysis Company Selectionlocal title:: 국제백신연구소 (IVI) 2024 백신 바이오의약품 국제표준 가이드라인 과정 개발 및 교육영향 분석 업체 선정grossbudgetlc: 55000000.0est_amount: 55000000.0

Mt Ref Id - 90461687

Deadline - Aug 08, 2025

Share

Similar Tenders :